152 related articles for article (PubMed ID: 32890314)
1. Evaluation of the Initiation Timing of Hydrocortisone in Adult Patients With Septic Shock.
Sacha GL; Chen AY; Palm NM; Duggal A
Shock; 2021 Apr; 55(4):488-494. PubMed ID: 32890314
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utilization of Stress Dose Hydrocortisone in Adult Patients With Septic Shock: A Retrospective Observational Study at a Large Academic Medical Center.
Sacha GL; Chen AY; Palm NM; Wang X; Li M; Duggal A
J Pharm Pract; 2023 Jun; 36(3):606-613. PubMed ID: 35156439
[No Abstract] [Full Text] [Related]
3. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
[TBL] [Abstract][Full Text] [Related]
4. Prescribing patterns of hydrocortisone in septic shock: a single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice.
Contrael KM; Killian AJ; Gregg SR; Buchman TG; Coopersmith CM
Crit Care Med; 2013 Oct; 41(10):2310-7. PubMed ID: 23787398
[TBL] [Abstract][Full Text] [Related]
5. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
[TBL] [Abstract][Full Text] [Related]
6. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
Bauer SR; Lam SW; Cha SS; Oyen LJ
J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
[TBL] [Abstract][Full Text] [Related]
7. Impact of Hyperoncotic Albumin on Duration of Vasopressor Support in Septic Shock: A Propensity Score-Matched Analysis.
Flannery AH; Owen GD; Coz A; Thompson Bastin ML; Patel K
Ann Pharmacother; 2021 May; 55(5):584-591. PubMed ID: 33016080
[TBL] [Abstract][Full Text] [Related]
8. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Early Versus Late Initiation of Hydrocortisone in Patients With Septic Shock in the ICU Setting.
Ragoonanan D; Allen B; Cannon C; Rottman-Pietrzak K; Bello A
Ann Pharmacother; 2022 Mar; 56(3):264-270. PubMed ID: 34109850
[TBL] [Abstract][Full Text] [Related]
10. The Timing of Initiating Hydrocortisone and Long-term Mortality in Septic Shock.
Zhang L; Gu WJ; Huang T; Lyu J; Yin H
Anesth Analg; 2023 Oct; 137(4):850-858. PubMed ID: 37171987
[TBL] [Abstract][Full Text] [Related]
11. Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes.
Nichols B; Kubis S; Hewlett J; Yehya N; Srinivasan V
Pediatr Crit Care Med; 2017 Sep; 18(9):e406-e414. PubMed ID: 28658197
[TBL] [Abstract][Full Text] [Related]
12. Timing of vasopressor initiation and mortality in septic shock: a cohort study.
Beck V; Chateau D; Bryson GL; Pisipati A; Zanotti S; Parrillo JE; Kumar A;
Crit Care; 2014 May; 18(3):R97. PubMed ID: 24887489
[TBL] [Abstract][Full Text] [Related]
13. Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.
Oh M; Patanwala AE; Alkhatib N; Almutairi A; Abraham I; Erstad B
Crit Care Med; 2020 Oct; 48(10):e906-e911. PubMed ID: 32701552
[TBL] [Abstract][Full Text] [Related]
14. Etomidate and mortality in cirrhotic patients with septic shock.
Cherfan AJ; Tamim HM; AlJumah A; Rishu AH; Al-Abdulkareem A; Al Knawy BA; Hajeer A; Tamimi W; Brits R; Arabi YM
BMC Clin Pharmacol; 2011 Dec; 11():22. PubMed ID: 22208901
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock.
Roberts RJ; Miano TA; Hammond DA; Patel GP; Chen JT; Phillips KM; Lopez N; Kashani K; Qadir N; Cairns CB; Mathews K; Park P; Khan A; Gilmore JF; Brown ART; Tsuei B; Handzel M; Chang AL; Duggal A; Lanspa M; Herbert JT; Martinez A; Tonna J; Ammar MA; Nazer LH; Heavner M; Pender E; Chambers L; Kenes MT; Kaufman D; Downey A; Brown B; Chaykosky D; Wolff A; Smith M; Nault K; Gong MN; Sevransky JE; Lat I;
Crit Care Med; 2020 Oct; 48(10):1445-1453. PubMed ID: 32706559
[TBL] [Abstract][Full Text] [Related]
16. Use of vasopressors for septic shock in the neonatal intensive care unit.
Foote HP; Benjamin DK; Greenberg RG; Clark RH; Hornik CP
J Perinatol; 2023 Oct; 43(10):1274-1280. PubMed ID: 37055478
[TBL] [Abstract][Full Text] [Related]
17. Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone as Adjunctive Therapy in Septic Shock: A Retrospective Cohort Study.
Lock AE; Gutierrez GC; Hand EO; Barthol CA; Attridge RL
Ann Pharmacother; 2023 Dec; 57(12):1375-1388. PubMed ID: 37026172
[TBL] [Abstract][Full Text] [Related]
18. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
Annane D; Renault A; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Martin C; Timsit JF; Misset B; Ali Benali M; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Amathieu R; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Maxime V; Bellissant E;
N Engl J Med; 2018 Mar; 378(9):809-818. PubMed ID: 29490185
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in vasopressor requirements for septic shock.
Bauman ZM; Killu KF; Rech MA; Bernabei-Combs JL; Gassner MY; Coba VE; Tovbin A; Kunkel PL; Mlynarek ME
Shock; 2014 Mar; 41(3):188-92. PubMed ID: 24365885
[TBL] [Abstract][Full Text] [Related]
20. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States.
Bosch NA; Teja B; Wunsch H; Walkey AJ
Ann Am Thorac Soc; 2021 Dec; 18(12):2049-2057. PubMed ID: 33975530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
